Share Price and Basic Stock Data
Last Updated: October 18, 2025, 7:00 pm
| PEG Ratio | -0.61 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Uflex Ltd, a prominent player in the packaging and containers industry, reported a price of ₹558 and a market capitalization of ₹4,029 Cr. The company recorded sales of ₹14,663 Cr for the fiscal year ending March 2023, reflecting a significant increase from ₹13,127 Cr in the previous fiscal year. However, in the subsequent fiscal year, sales are anticipated to decline to ₹13,364 Cr before recovering to ₹15,036 Cr in March 2025. Quarterly sales fluctuated, with the highest quarterly sales recorded at ₹4,032 Cr in June 2022, which subsequently declined to ₹3,258 Cr in June 2023. Such a trend raises questions about market demand and operational efficiency. Uflex’s ability to navigate these fluctuations will be crucial for maintaining its position in the competitive packaging sector, especially as it faces challenges such as raw material costs and changing consumer preferences.
Profitability and Efficiency Metrics
Uflex’s profitability metrics indicate a mixed performance. The operating profit margin (OPM) stood at 12% for the fiscal year ending March 2025, a decline from 17% in March 2022. The net profit for March 2023 was ₹481 Cr, dropping significantly to a net loss of ₹691 Cr in March 2024, before recovering to ₹142 Cr in March 2025. The earnings per share (EPS) mirrored this trend, with a reported EPS of ₹66.57 in March 2023, plummeting to a negative ₹95.69 in March 2024, and rebounding to ₹19.71 in March 2025. The interest coverage ratio (ICR) stood at 2.61x, indicating that the company can cover its interest obligations adequately, although this is lower than previous years. The cash conversion cycle (CCC) has increased to 101 days, suggesting that Uflex may be facing challenges in managing its working capital effectively, potentially impacting liquidity and operational efficiency.
Balance Sheet Strength and Financial Ratios
Uflex’s balance sheet exhibits both strengths and vulnerabilities. As of March 2025, the company reported total borrowings of ₹8,353 Cr against reserves of ₹7,324 Cr, resulting in a debt-to-equity ratio of 1.10, which is relatively high and may concern investors regarding financial stability. The current ratio of 1.31 indicates that Uflex has sufficient short-term assets to cover its short-term liabilities, though this is a decline from previous years. The return on equity (ROE) for March 2025 was reported at 1.92%, a significant drop from 16.42% in March 2022, reflecting reduced profitability relative to shareholders’ equity. Conversely, the return on capital employed (ROCE) of 8.66% suggests that while Uflex is generating some returns on its capital, it is below the industry average, highlighting the need for improved capital efficiency. The company’s ability to manage its liabilities while enhancing profitability will be critical for its future financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Uflex indicates a stable promoter holding at 44.58%, which has remained consistent across reporting periods. Foreign Institutional Investors (FIIs) held 7.62% of the company’s shares as of March 2025, showing a slight decline from earlier periods, which could signal reduced investor confidence. Domestic Institutional Investors (DIIs) maintained a minimal stake of 0.52%, while public ownership accounted for 47.30%, suggesting a broad retail investor base. The total number of shareholders has decreased to 44,972, down from 61,970 in March 2023, potentially indicating waning interest in the stock. This shift in shareholder dynamics could affect Uflex’s stock performance and market perception, emphasizing the need for management to enhance shareholder value and restore confidence in its growth strategy.
Outlook, Risks, and Final Insight
If Uflex can sustain its recovery in net profit and operating margins, it may stabilize its position in the packaging industry. However, the company faces risks related to its high debt levels, which could strain cash flow if profitability does not improve. Additionally, the increasing cash conversion cycle may hinder operational efficiency, necessitating strategic management of working capital. If margins improve and the company manages to optimize its cost structure, there is potential for Uflex to enhance shareholder returns and attract more institutional investment. Furthermore, addressing the concerns around liquidity and operational efficiency will be vital for ensuring long-term growth and competitiveness in a challenging market landscape. The coming quarters will be crucial in determining whether Uflex can effectively navigate these challenges and leverage its strengths to foster sustainable growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Uflex Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Tin Works Ltd | 150 Cr. | 144 | 225/133 | 11.2 | 207 | 0.56 % | 7.95 % | 5.88 % | 10.0 |
| Gujarat Containers Ltd | 98.9 Cr. | 175 | 191/160 | 13.2 | 90.5 | 0.86 % | 18.4 % | 17.4 % | 10.0 |
| Goblin India Ltd | 20.0 Cr. | 14.5 | 43.9/12.5 | 10.3 | 31.2 | 0.00 % | 7.73 % | 4.63 % | 10.0 |
| G K P Printing & Packaging Ltd | 13.7 Cr. | 6.24 | 9.11/4.85 | 18.1 | 10.2 | 0.00 % | 4.87 % | 3.87 % | 10.0 |
| Garware Hi Tech Films Ltd | 7,490 Cr. | 3,224 | 5,378/2,317 | 23.0 | 1,021 | 0.37 % | 20.6 % | 15.0 % | 10.0 |
| Industry Average | 2,085.79 Cr | 339.00 | 65.38 | 180.04 | 0.31% | 12.76% | 24.70% | 7.38 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,032 | 3,768 | 3,483 | 3,380 | 3,258 | 3,369 | 3,309 | 3,426 | 3,654 | 3,833 | 3,735 | 3,814 | 3,901 |
| Expenses | 3,321 | 3,356 | 3,219 | 3,011 | 2,975 | 2,984 | 2,978 | 3,060 | 3,245 | 3,441 | 3,281 | 3,404 | 3,447 |
| Operating Profit | 711 | 412 | 264 | 370 | 284 | 386 | 332 | 366 | 408 | 392 | 454 | 410 | 454 |
| OPM % | 18% | 11% | 8% | 11% | 9% | 11% | 10% | 11% | 11% | 10% | 12% | 11% | 12% |
| Other Income | 14 | 81 | -70 | -52 | -362 | 20 | -64 | -319 | -149 | -73 | 65 | 132 | 21 |
| Interest | 105 | 105 | 133 | 130 | 135 | 132 | 140 | 128 | 162 | 178 | 174 | 184 | 199 |
| Depreciation | 144 | 146 | 144 | 166 | 160 | 164 | 166 | 165 | 173 | 173 | 172 | 176 | 187 |
| Profit before tax | 476 | 242 | -83 | 22 | -373 | 110 | -39 | -247 | -76 | -31 | 173 | 182 | 89 |
| Tax % | 21% | 21% | 3% | 96% | 12% | 42% | 72% | 10% | 30% | 108% | 21% | 7% | 35% |
| Net Profit | 375 | 191 | -85 | 1 | -416 | 63 | -67 | -271 | -98 | -65 | 137 | 169 | 58 |
| EPS in Rs | 51.86 | 26.41 | -11.83 | 0.12 | -57.63 | 8.77 | -9.31 | -37.51 | -13.63 | -8.95 | 18.95 | 23.34 | 8.03 |
Last Updated: August 20, 2025, 1:55 am
Below is a detailed analysis of the quarterly data for Uflex Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 3,901.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,814.00 Cr. (Mar 2025) to 3,901.00 Cr., marking an increase of 87.00 Cr..
- For Expenses, as of Jun 2025, the value is 3,447.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,404.00 Cr. (Mar 2025) to 3,447.00 Cr., marking an increase of 43.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 454.00 Cr.. The value appears strong and on an upward trend. It has increased from 410.00 Cr. (Mar 2025) to 454.00 Cr., marking an increase of 44.00 Cr..
- For OPM %, as of Jun 2025, the value is 12.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Mar 2025) to 12.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 132.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 111.00 Cr..
- For Interest, as of Jun 2025, the value is 199.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 184.00 Cr. (Mar 2025) to 199.00 Cr., marking an increase of 15.00 Cr..
- For Depreciation, as of Jun 2025, the value is 187.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 176.00 Cr. (Mar 2025) to 187.00 Cr., marking an increase of 11.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 89.00 Cr.. The value appears to be declining and may need further review. It has decreased from 182.00 Cr. (Mar 2025) to 89.00 Cr., marking a decrease of 93.00 Cr..
- For Tax %, as of Jun 2025, the value is 35.00%. The value appears to be increasing, which may not be favorable. It has increased from 7.00% (Mar 2025) to 35.00%, marking an increase of 28.00%.
- For Net Profit, as of Jun 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 169.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 111.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 8.03. The value appears to be declining and may need further review. It has decreased from 23.34 (Mar 2025) to 8.03, marking a decrease of 15.31.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:13 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,826 | 6,130 | 6,366 | 6,505 | 6,802 | 7,957 | 7,405 | 8,889 | 13,127 | 14,663 | 13,364 | 15,036 | 15,283 |
| Expenses | 5,137 | 5,395 | 5,561 | 5,630 | 5,921 | 6,969 | 6,324 | 7,085 | 10,956 | 12,913 | 11,976 | 13,344 | 13,573 |
| Operating Profit | 688 | 735 | 805 | 874 | 881 | 988 | 1,081 | 1,804 | 2,171 | 1,749 | 1,387 | 1,692 | 1,710 |
| OPM % | 12% | 12% | 13% | 13% | 13% | 12% | 15% | 20% | 17% | 12% | 10% | 11% | 11% |
| Other Income | 29 | 18 | 38 | 25 | 22 | 19 | 28 | 23 | 71 | -21 | -745 | -51 | 146 |
| Interest | 233 | 187 | 176 | 187 | 197 | 218 | 225 | 229 | 322 | 473 | 536 | 698 | 735 |
| Depreciation | 267 | 279 | 286 | 318 | 352 | 381 | 403 | 456 | 537 | 599 | 655 | 695 | 708 |
| Profit before tax | 217 | 286 | 382 | 395 | 354 | 409 | 481 | 1,142 | 1,382 | 656 | -549 | 248 | 413 |
| Tax % | 7% | 11% | 17% | 11% | 12% | 23% | 23% | 26% | 20% | 27% | 26% | 43% | |
| Net Profit | 202 | 256 | 317 | 351 | 312 | 315 | 371 | 844 | 1,099 | 481 | -691 | 142 | 299 |
| EPS in Rs | 27.92 | 35.28 | 43.46 | 48.26 | 43.00 | 43.46 | 51.21 | 116.73 | 152.09 | 66.57 | -95.69 | 19.71 | 41.37 |
| Dividend Payout % | 9% | 8% | 7% | 7% | 5% | 5% | 4% | 2% | 2% | 5% | -1% | 15% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 26.73% | 23.83% | 10.73% | -11.11% | 0.96% | 17.78% | 127.49% | 30.21% | -56.23% | -243.66% | 120.55% |
| Change in YoY Net Profit Growth (%) | 0.00% | -2.90% | -13.10% | -21.84% | 12.07% | 16.82% | 109.72% | -97.28% | -86.45% | -187.43% | 364.21% |
Uflex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 15% |
| 3 Years: | 5% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -8% |
| 3 Years: | -40% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 11% |
| 3 Years: | -11% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: July 25, 2025, 2:09 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 |
| Reserves | 2,751 | 2,935 | 3,376 | 3,572 | 3,907 | 4,232 | 4,625 | 5,484 | 6,624 | 7,433 | 7,153 | 7,324 |
| Borrowings | 2,416 | 2,210 | 2,139 | 2,102 | 2,079 | 2,105 | 3,626 | 4,041 | 4,787 | 5,704 | 6,947 | 8,353 |
| Other Liabilities | 1,356 | 1,250 | 1,217 | 1,402 | 1,629 | 1,550 | 1,693 | 2,222 | 2,959 | 3,229 | 3,176 | 3,687 |
| Total Liabilities | 6,595 | 6,468 | 6,804 | 7,148 | 7,688 | 7,960 | 10,016 | 11,820 | 14,441 | 16,438 | 17,348 | 19,437 |
| Fixed Assets | 3,378 | 3,240 | 3,255 | 3,394 | 3,766 | 3,759 | 3,808 | 5,032 | 6,417 | 7,786 | 8,223 | 8,739 |
| CWIP | 74 | 32 | 229 | 498 | 196 | 261 | 2,007 | 1,518 | 671 | 466 | 538 | 725 |
| Investments | 126 | 138 | 111 | 76 | 85 | 42 | 199 | 205 | 212 | 191 | 170 | 145 |
| Other Assets | 3,017 | 3,058 | 3,210 | 3,180 | 3,641 | 3,898 | 4,003 | 5,065 | 7,141 | 7,994 | 8,416 | 9,828 |
| Total Assets | 6,595 | 6,468 | 6,804 | 7,148 | 7,688 | 7,960 | 10,016 | 11,820 | 14,441 | 16,438 | 17,348 | 19,437 |
Below is a detailed analysis of the balance sheet data for Uflex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 72.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 72.00 Cr..
- For Reserves, as of Mar 2025, the value is 7,324.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,153.00 Cr. (Mar 2024) to 7,324.00 Cr., marking an increase of 171.00 Cr..
- For Borrowings, as of Mar 2025, the value is 8,353.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 6,947.00 Cr. (Mar 2024) to 8,353.00 Cr., marking an increase of 1,406.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 3,687.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,176.00 Cr. (Mar 2024) to 3,687.00 Cr., marking an increase of 511.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 19,437.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17,348.00 Cr. (Mar 2024) to 19,437.00 Cr., marking an increase of 2,089.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 8,739.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,223.00 Cr. (Mar 2024) to 8,739.00 Cr., marking an increase of 516.00 Cr..
- For CWIP, as of Mar 2025, the value is 725.00 Cr.. The value appears strong and on an upward trend. It has increased from 538.00 Cr. (Mar 2024) to 725.00 Cr., marking an increase of 187.00 Cr..
- For Investments, as of Mar 2025, the value is 145.00 Cr.. The value appears to be declining and may need further review. It has decreased from 170.00 Cr. (Mar 2024) to 145.00 Cr., marking a decrease of 25.00 Cr..
- For Other Assets, as of Mar 2025, the value is 9,828.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,416.00 Cr. (Mar 2024) to 9,828.00 Cr., marking an increase of 1,412.00 Cr..
- For Total Assets, as of Mar 2025, the value is 19,437.00 Cr.. The value appears strong and on an upward trend. It has increased from 17,348.00 Cr. (Mar 2024) to 19,437.00 Cr., marking an increase of 2,089.00 Cr..
However, the Borrowings (8,353.00 Cr.) are higher than the Reserves (7,324.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 686.00 | 733.00 | 803.00 | 872.00 | 879.00 | 986.00 | -2.00 | -3.00 | -2.00 | -4.00 | -5.00 | -7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 94 | 90 | 85 | 93 | 104 | 94 | 96 | 99 | 98 | 80 | 94 | 91 |
| Inventory Days | 60 | 63 | 64 | 70 | 72 | 63 | 73 | 89 | 86 | 91 | 84 | 100 |
| Days Payable | 86 | 72 | 80 | 98 | 108 | 79 | 90 | 104 | 92 | 85 | 90 | 90 |
| Cash Conversion Cycle | 69 | 80 | 68 | 64 | 68 | 78 | 79 | 83 | 92 | 87 | 88 | 101 |
| Working Capital Days | 22 | 23 | 23 | 22 | 36 | 32 | 31 | 45 | 56 | 41 | 36 | 20 |
| ROCE % | 9% | 9% | 10% | 10% | 9% | 10% | 10% | 15% | 17% | 10% | 6% | 8% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 40,093 | 0.18 | 2.4 | 40,093 | 2025-04-22 15:56:52 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 19.71 | -95.69 | 66.57 | 152.09 | 116.73 |
| Diluted EPS (Rs.) | 19.71 | -95.69 | 66.57 | 152.09 | 116.73 |
| Cash EPS (Rs.) | 118.09 | -3.17 | 150.56 | 226.63 | 179.94 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1023.00 | 1000.53 | 1039.38 | 927.25 | 769.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1023.00 | 1000.53 | 1039.38 | 927.25 | 769.49 |
| Revenue From Operations / Share (Rs.) | 2082.23 | 1850.62 | 2030.49 | 1817.87 | 1231.21 |
| PBDIT / Share (Rs.) | 254.02 | 211.36 | 261.17 | 315.74 | 253.01 |
| PBIT / Share (Rs.) | 157.79 | 120.59 | 178.22 | 241.35 | 189.90 |
| PBT / Share (Rs.) | 36.51 | -74.24 | 91.88 | 191.42 | 158.17 |
| Net Profit / Share (Rs.) | 21.86 | -93.94 | 67.61 | 152.25 | 116.83 |
| NP After MI And SOA / Share (Rs.) | 19.71 | -95.69 | 66.57 | 152.09 | 116.73 |
| PBDIT Margin (%) | 12.19 | 11.42 | 12.86 | 17.36 | 20.54 |
| PBIT Margin (%) | 7.57 | 6.51 | 8.77 | 13.27 | 15.42 |
| PBT Margin (%) | 1.75 | -4.01 | 4.52 | 10.53 | 12.84 |
| Net Profit Margin (%) | 1.04 | -5.07 | 3.32 | 8.37 | 9.48 |
| NP After MI And SOA Margin (%) | 0.94 | -5.17 | 3.27 | 8.36 | 9.48 |
| Return on Networth / Equity (%) | 1.92 | -9.57 | 6.41 | 16.42 | 15.16 |
| Return on Capital Employeed (%) | 8.78 | 7.20 | 11.10 | 16.81 | 15.67 |
| Return On Assets (%) | 0.73 | -3.98 | 2.92 | 7.60 | 7.12 |
| Long Term Debt / Equity (X) | 0.65 | 0.57 | 0.46 | 0.45 | 0.50 |
| Total Debt / Equity (X) | 1.10 | 0.93 | 0.73 | 0.68 | 0.64 |
| Asset Turnover Ratio (%) | 0.81 | 0.79 | 0.63 | 0.64 | 0.62 |
| Current Ratio (X) | 1.31 | 1.46 | 1.56 | 1.64 | 1.55 |
| Quick Ratio (X) | 0.91 | 1.09 | 1.08 | 1.19 | 1.18 |
| Inventory Turnover Ratio (X) | 6.75 | 3.88 | 3.36 | 4.03 | 3.85 |
| Dividend Payout Ratio (NP) (%) | 5.07 | -3.13 | 4.50 | 1.64 | 1.71 |
| Dividend Payout Ratio (CP) (%) | 0.86 | -60.99 | 2.00 | 1.10 | 1.11 |
| Earning Retention Ratio (%) | 94.93 | 103.13 | 95.50 | 98.36 | 98.29 |
| Cash Earning Retention Ratio (%) | 99.14 | 160.99 | 98.00 | 98.90 | 98.89 |
| Interest Coverage Ratio (X) | 2.63 | 2.85 | 3.98 | 7.07 | 7.98 |
| Interest Coverage Ratio (Post Tax) (X) | 1.48 | 1.36 | 2.35 | 4.53 | 4.68 |
| Enterprise Value (Cr.) | 10561.28 | 8579.76 | 6834.46 | 8380.47 | 5629.29 |
| EV / Net Operating Revenue (X) | 0.70 | 0.64 | 0.46 | 0.63 | 0.63 |
| EV / EBITDA (X) | 5.76 | 5.62 | 3.62 | 3.68 | 3.08 |
| MarketCap / Net Operating Revenue (X) | 0.23 | 0.21 | 0.16 | 0.33 | 0.30 |
| Retention Ratios (%) | 94.92 | 103.13 | 95.49 | 98.35 | 98.28 |
| Price / BV (X) | 0.48 | 0.40 | 0.32 | 0.65 | 0.49 |
| Price / Net Operating Revenue (X) | 0.23 | 0.21 | 0.16 | 0.33 | 0.30 |
| EarningsYield | 0.03 | -0.23 | 0.19 | 0.24 | 0.30 |
After reviewing the key financial ratios for Uflex Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
- For Diluted EPS (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
- For Cash EPS (Rs.), as of Mar 25, the value is 118.09. This value is within the healthy range. It has increased from -3.17 (Mar 24) to 118.09, marking an increase of 121.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,023.00. It has increased from 1,000.53 (Mar 24) to 1,023.00, marking an increase of 22.47.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,023.00. It has increased from 1,000.53 (Mar 24) to 1,023.00, marking an increase of 22.47.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,082.23. It has increased from 1,850.62 (Mar 24) to 2,082.23, marking an increase of 231.61.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 254.02. This value is within the healthy range. It has increased from 211.36 (Mar 24) to 254.02, marking an increase of 42.66.
- For PBIT / Share (Rs.), as of Mar 25, the value is 157.79. This value is within the healthy range. It has increased from 120.59 (Mar 24) to 157.79, marking an increase of 37.20.
- For PBT / Share (Rs.), as of Mar 25, the value is 36.51. This value is within the healthy range. It has increased from -74.24 (Mar 24) to 36.51, marking an increase of 110.75.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 21.86. This value is within the healthy range. It has increased from -93.94 (Mar 24) to 21.86, marking an increase of 115.80.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
- For PBDIT Margin (%), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 11.42 (Mar 24) to 12.19, marking an increase of 0.77.
- For PBIT Margin (%), as of Mar 25, the value is 7.57. This value is below the healthy minimum of 10. It has increased from 6.51 (Mar 24) to 7.57, marking an increase of 1.06.
- For PBT Margin (%), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 10. It has increased from -4.01 (Mar 24) to 1.75, marking an increase of 5.76.
- For Net Profit Margin (%), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 5. It has increased from -5.07 (Mar 24) to 1.04, marking an increase of 6.11.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 8. It has increased from -5.17 (Mar 24) to 0.94, marking an increase of 6.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.92. This value is below the healthy minimum of 15. It has increased from -9.57 (Mar 24) to 1.92, marking an increase of 11.49.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.78. This value is below the healthy minimum of 10. It has increased from 7.20 (Mar 24) to 8.78, marking an increase of 1.58.
- For Return On Assets (%), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has increased from -3.98 (Mar 24) to 0.73, marking an increase of 4.71.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.65. This value is within the healthy range. It has increased from 0.57 (Mar 24) to 0.65, marking an increase of 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.10. This value exceeds the healthy maximum of 1. It has increased from 0.93 (Mar 24) to 1.10, marking an increase of 0.17.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has increased from 0.79 (Mar 24) to 0.81, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.31, marking a decrease of 0.15.
- For Quick Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.09 (Mar 24) to 0.91, marking a decrease of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.75. This value is within the healthy range. It has increased from 3.88 (Mar 24) to 6.75, marking an increase of 2.87.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 5.07. This value is below the healthy minimum of 20. It has increased from -3.13 (Mar 24) to 5.07, marking an increase of 8.20.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 20. It has increased from -60.99 (Mar 24) to 0.86, marking an increase of 61.85.
- For Earning Retention Ratio (%), as of Mar 25, the value is 94.93. This value exceeds the healthy maximum of 70. It has decreased from 103.13 (Mar 24) to 94.93, marking a decrease of 8.20.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 99.14. This value exceeds the healthy maximum of 70. It has decreased from 160.99 (Mar 24) to 99.14, marking a decrease of 61.85.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.63. This value is below the healthy minimum of 3. It has decreased from 2.85 (Mar 24) to 2.63, marking a decrease of 0.22.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 3. It has increased from 1.36 (Mar 24) to 1.48, marking an increase of 0.12.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,561.28. It has increased from 8,579.76 (Mar 24) to 10,561.28, marking an increase of 1,981.52.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 1. It has increased from 0.64 (Mar 24) to 0.70, marking an increase of 0.06.
- For EV / EBITDA (X), as of Mar 25, the value is 5.76. This value is within the healthy range. It has increased from 5.62 (Mar 24) to 5.76, marking an increase of 0.14.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 94.92. This value exceeds the healthy maximum of 70. It has decreased from 103.13 (Mar 24) to 94.92, marking a decrease of 8.21.
- For Price / BV (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.40 (Mar 24) to 0.48, marking an increase of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from -0.23 (Mar 24) to 0.03, marking an increase of 0.26.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uflex Ltd:
- Net Profit Margin: 1.04%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.78% (Industry Average ROCE: 12.76%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.92% (Industry Average ROE: 24.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.48
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.91
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.9 (Industry average Stock P/E: 65.38)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.1
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.04%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | 305, Third Floor, Bhanot Corner, New Delhi Delhi 110048 | secretarial@uflexltd.com http://www.uflexltd.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashok Chaturvedi | Chairman & Managing Director |
| Mr. Jeevaraj Gopal Pillai | Whole Time Director |
| Mrs. Sujit Kumar Varma | Independent Director |
| Mr. Ghyanendra Nath Bajpai | Independent Director |
| Mrs. Rashmi Verma | Independent Director |
| Mr. Paresh Nath Sharma | Independent Director |
FAQ
What is the intrinsic value of Uflex Ltd?
Uflex Ltd's intrinsic value (as of 19 October 2025) is 376.69 which is 31.14% lower the current market price of 547.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,948 Cr. market cap, FY2025-2026 high/low of 686/438, reserves of ₹7,324 Cr, and liabilities of 19,437 Cr.
What is the Market Cap of Uflex Ltd?
The Market Cap of Uflex Ltd is 3,948 Cr..
What is the current Stock Price of Uflex Ltd as on 19 October 2025?
The current stock price of Uflex Ltd as on 19 October 2025 is 547.
What is the High / Low of Uflex Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Uflex Ltd stocks is 686/438.
What is the Stock P/E of Uflex Ltd?
The Stock P/E of Uflex Ltd is 13.9.
What is the Book Value of Uflex Ltd?
The Book Value of Uflex Ltd is 1,024.
What is the Dividend Yield of Uflex Ltd?
The Dividend Yield of Uflex Ltd is 0.55 %.
What is the ROCE of Uflex Ltd?
The ROCE of Uflex Ltd is 7.75 %.
What is the ROE of Uflex Ltd?
The ROE of Uflex Ltd is 3.29 %.
What is the Face Value of Uflex Ltd?
The Face Value of Uflex Ltd is 10.0.